OMB
.report
Search
21 USC 353b Sec 503B FFDCA OCT 2022
Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
21 USC 353b Sec 503B FFDCA OCT 2022
OMB: 0910-0800
OMB.report
HHS/FDA
OMB 0910-0800
ICR 202210-0910-015
IC 256583
21 USC 353b Sec 503B FFDCA OCT 2022
( )
Document [pdf]
Download:
pdf
|
pdf
File Type
application/pdf
File Title
about_blank
Author
DHC
File Modified
2022-10-25
File Created
2022-10-25
© 2024 OMB.report |
Privacy Policy